AU4865796A - Ophthalmic compositions including peptides and peptide derivatives and methods for using same - Google Patents

Ophthalmic compositions including peptides and peptide derivatives and methods for using same

Info

Publication number
AU4865796A
AU4865796A AU48657/96A AU4865796A AU4865796A AU 4865796 A AU4865796 A AU 4865796A AU 48657/96 A AU48657/96 A AU 48657/96A AU 4865796 A AU4865796 A AU 4865796A AU 4865796 A AU4865796 A AU 4865796A
Authority
AU
Australia
Prior art keywords
methods
same
compositions including
peptide derivatives
ophthalmic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48657/96A
Inventor
John C Baker
James P Currie
Stanley W. Huth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU4865796A publication Critical patent/AU4865796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
AU48657/96A 1995-02-17 1996-02-08 Ophthalmic compositions including peptides and peptide derivatives and methods for using same Abandoned AU4865796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39000695A 1995-02-17 1995-02-17
PCT/US1996/001728 WO1996025183A2 (en) 1995-02-17 1996-02-08 Ophthalmic compositions including peptides and peptide derivatives and methods for using same
US390006 1999-09-03

Publications (1)

Publication Number Publication Date
AU4865796A true AU4865796A (en) 1996-09-04

Family

ID=23540656

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48657/96A Abandoned AU4865796A (en) 1995-02-17 1996-02-08 Ophthalmic compositions including peptides and peptide derivatives and methods for using same

Country Status (2)

Country Link
AU (1) AU4865796A (en)
WO (1) WO1996025183A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482799B1 (en) 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
WO2002064183A1 (en) * 2001-02-09 2002-08-22 Johnson & Johnson Vision Care, Inc. Biomedical devices with antimicrobial cationic peptide and protein coatings
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
US7368127B2 (en) 2002-12-19 2008-05-06 Johnson & Johnson Vision Care, Inc. Biomedical devices with peptide containing coatings
US7939501B2 (en) * 2003-04-15 2011-05-10 Smith Francis X Ophthalmic and contact lens solutions containing peptides as preservative
CN101212906B (en) * 2005-07-01 2011-09-28 凯恩生物科技有限公司 Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US5035859A (en) * 1989-11-21 1991-07-30 Schering Corporation Contact lens disinfecting system
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
ES2154344T3 (en) * 1994-09-01 2001-04-01 Novozymes As BASIC PROTEIN COMPOSITION TO KILL OR INHIBIT MICROBIAL CELLS.

Also Published As

Publication number Publication date
WO1996025183A2 (en) 1996-08-22
WO1996025183A3 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
AU5801296A (en) Crosslinkable polypeptide compositions
AU3698295A (en) Amino purine-beta -d-ribofuranuronamide derivatives
AU7358398A (en) Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
AU7203496A (en) Novel peptides
AU6124196A (en) Novel dolastatin derivatives, their preparation and use
AU7068896A (en) Protein composition derived from sesame seed and use thereof
AU2972097A (en) Peptide derivatives
AU4413096A (en) Phenylalanine free proteins
AU4873197A (en) Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof
AU6489996A (en) Methods for increasing protein expression
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU1803597A (en) Peptide derivatives
AU7627496A (en) Glycine derivatives
AU3461095A (en) Compositions and methods for delivery of polypeptides
AU7292196A (en) Cyclopeptide derivatives
AU4006695A (en) Calcineurin interacting protein compositions and methods
AU5166296A (en) New peptides with immunomodulatory effects
AU5532396A (en) Pharmaceutical preparations derived from european mistletoe
AU2650697A (en) Ophthalmic preparations
AU4865796A (en) Ophthalmic compositions including peptides and peptide derivatives and methods for using same
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
AU5061698A (en) Peptide derivatives